Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric Cancer
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Elderly patients have poor tolerance and physical condition, we will prove 2-week schedule of
oxaliplatin plus S-1 have a good efficacy and a better safety for elderly patients with
advanced or recurrent gastric cancer.